OtherArticle
Activation of NF-kB pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells
Chiara Riganti, Sophie Doublier, Costanzo Costamagna, Elisabetta Aldieri, Gianpiero Pescarmona, Dario Ghigo and Amalia Bosia
Molecular Pharmacology May 7, 2008, DOI: https://doi.org/10.1124/mol.108.045286
Chiara Riganti
Sophie Doublier
Costanzo Costamagna
Elisabetta Aldieri
Gianpiero Pescarmona
Dario Ghigo
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
Activation of NF-kB pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells
Chiara Riganti, Sophie Doublier, Costanzo Costamagna, Elisabetta Aldieri, Gianpiero Pescarmona, Dario Ghigo and Amalia Bosia
Molecular Pharmacology May 7, 2008, DOI: https://doi.org/10.1124/mol.108.045286
OtherArticle
Activation of NF-kB pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells
Chiara Riganti, Sophie Doublier, Costanzo Costamagna, Elisabetta Aldieri, Gianpiero Pescarmona, Dario Ghigo and Amalia Bosia
Molecular Pharmacology May 7, 2008, DOI: https://doi.org/10.1124/mol.108.045286
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement